Dr Sarah Perkins joined GW4 as its Director in September 2016. Prior to this, she was Programme Director (Research) at the Faculty of Medicine at Imperial College London, managing a world class research portfolio in one of the largest medical faculties in Europe. Appointed in 2009, her role involved developing and delivering research strategy, and leading initiatives such as Research Excellence Framework submission, and working closely with several NHS Trusts through the Imperial Academic Health Sciences Centre (AHSC) to foster collaboration and implement research strategy at a senior level, exemplified by delivering and renewing one of the largest NIHR Biomedical Research Centres. Her achievements were recognised in 2013 when she was shortlisted in the Women of the Future Awards, and she is also a Fellow of Westminster Abbey Institute.
Despite an extensive literature exploring the costs and benefits of Academic-Industry research consortia; and intra/inter-institutional collaboration through block-funded research centres, little attention has been paid to understanding the drivers behind and ongoing performance management of voluntary, formally-constituted, cross-institutional, collaborations within academia. Yet various such consortia, e.g. Eastern ARC, GW4, N8, U4 now exist. How do …
|Speakers:||Sarah Tetley, Dr Sarah Perkins, Dr Gijs Coucke, Dr Alice Brewer, Dr Helen Turner, Dr Nick Goldspink|